Breast cancer and pregnancy: the ultimate challenge

Clinical Oncology : a Journal of the Royal College of Radiologists
R M Clark, T Chua

Abstract

An update on a series of 413 patients with carcinoma of the breast associated with pregnancy and referred to The Princess Margaret Hospital between 1931 and 1985 is presented. Coincident pregnancy is seriously detrimental to survival and, to a lesser degree, lactation. Subsequent pregnancies do not affect survival provided the pregnancy occurs at least one year after treatment for breast cancer, and preferably two years. Subsequent pregnancy may confer an improved prognosis. Interference in terms of a therapeutic abortion in breast cancer with coincident, lactational and subsequent pregnancies, is associated with decreased survival and ovarian ablation confers no benefit. Investigation and local treatment for coincident pregnancies should be limited to the absolute minimum necessary to achieve local control. Aggressive management should be reserved for acute life-threatening situations and then only after frank discussion with the patient. Adjuvant therapy is recommended after delivery and for lactational presentations, even if nodes are negative, due to the poor prognosis.

References

Jul 1, 1978·International Journal of Radiation Oncology, Biology, Physics·R M Clark, J Reid
Jan 1, 1962·Radiology·M V PETERS

❮ Previous
Next ❯

Citations

Jul 1, 1994·Cancer·J A Petrek
Jul 1, 1994·Cancer·J A Petrek
Jan 12, 2011·Archives of Gynecology and Obstetrics·Barbara LawrenzTanja Fehm
Aug 18, 2010·Breast Cancer Research and Treatment·Ma Concepción Sánchez Martínez, Amparo Ruiz Simón
Feb 2, 2002·Current Oncology Reports·Philip J DiSaia, Wendy R Brewster
Oct 1, 1995·American Journal of Surgery·C E Scott-Conner, S J Schorr
Nov 26, 1999·The Surgical Clinics of North America·M L GemignaniP I Borgen
Jun 25, 2004·Current Surgery·Debra G Koivunen
Mar 26, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S S UpponiA D Purushotham
Dec 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K Mokbel
Aug 1, 1997·Surgical Oncology·H M KuererP I Tartter
Dec 9, 2003·The Breast : Official Journal of the European Society of Mastology·Niels Kroman, Henning T Mouridsen
Jul 3, 1998·Critical Reviews in Oncology/hematology·A Surbone, J A Petrek
Jan 29, 2009·Human Reproduction Update·M HickeyM Friedlander
Jun 8, 1991·BMJ : British Medical Journal·R M Clark
Dec 13, 2006·BMJ : British Medical Journal·Angela IvesJames Semmens
Jul 27, 2011·Therapeutic Advances in Medical Oncology·Sophie E McGrath, Alistair Ring
Dec 15, 2010·The Oncologist·Jennifer K Litton, Richard L Theriault
Apr 28, 2009·Women's Health·Jennifer K LittonAna M Gonzalez-Angulo
Jul 8, 2011·Surgical Oncology·E VoulgarisN Pavlidis
Sep 24, 2009·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Edouard VinatierDenis Vinatier
May 22, 2009·Gynécologie, obstétrique & fertilité·E VinatierD Vinatier
Apr 25, 2012·Obstetrics and Gynecology International·Michelle L MatthewsTerry Sarantou
Jul 25, 2008·Gynécologie, obstétrique & fertilité·T KojouharovaC Mathelin
Mar 27, 2007·The Breast : Official Journal of the European Society of Mastology·Nicola Roche
Apr 29, 2010·Psycho-oncology·Jessica R GormanJohn P Pierce
Jun 18, 1998·Obstetrics and Gynecology Clinics of North America·J I Sorosky, C E Scott-Conner
Apr 20, 2010·Journal of Surgical Oncology·Eelco de BreeDimitris D Tsiftsis
Aug 16, 2014·Magyar sebészet·János TajtiGyörgy Lázár
Nov 27, 2004·The Breast : Official Journal of the European Society of Mastology·L Barthelmes, C A Gateley
Jan 5, 2006·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·P Eedarapalli, S Jain
Sep 1, 1996·Seminars in Surgical Oncology·D E Merkel
Sep 17, 1996·International Journal of Cancer. Journal International Du Cancer·A E LethabyV J Harvey
Jul 15, 2004·International Journal of Cancer. Journal International Du Cancer·Lena RosenbergPer Hall
Dec 24, 2002·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Christobel SaundersJames Semmens
Jan 1, 1995·Cancer·K I Pritchard, C A Sawka
Jun 8, 1991·BMJ : British Medical Journal·R C Lyle
Aug 29, 2001·The Oncologist·K I Pritchard
Apr 24, 2001·Current Opinion in Obstetrics & Gynecology·V Sivanesaratnam
Oct 9, 2002·Clinical Obstetrics and Gynecology·WilliamH Hindle, Susana Gonzalez
Feb 1, 1996·Obstetrical & Gynecological Survey·N M AntonelliJ A Kuller
Feb 1, 1996·Obstetrical & Gynecological Survey·N M AntonelliJ A Kuller
Jul 6, 2000·Acta Clinica Belgica·K SchotteS Van Belle
Oct 4, 2017·Southern Medical Journal·Michael R ShafiqueHyo Sook Han

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
R M Clark, J Reid
The British Journal of Surgery
G G RibeiroM Jones
American Journal of Obstetrics and Gynecology
D ZemlickisG Koren
© 2022 Meta ULC. All rights reserved